DNA and Genetics Patents: What Impact Will the Myriad Decision Have?
Dentons
June 18, 2013
2 pages
Association for Molecular Pathology v. Myriad Genetics: SCOTUS Holds Isolated Genes Not Patentable
Not a Biotech Company? What Myriad Might Mean For You
Haynes and Boone
June 18, 2013
2 pages
U.S. Supreme Court Holds That Portions of DNA Isolated From Naturally Occurring DNA Are Not Patent Eligible But That Synthetically Created DNA Is Patent Eligible
Myriad: A Tempest in the Biotechnology Industry Teapot?
Wilson Sonsini
June 17, 2013
2 pages
US Supreme Court rules isolated DNA is not patent-eligible
Norton Rose Fulbright
June 18, 2013
3 pages
Supreme Court Holds That Companies Can Patent cDNA Segments but Not Naturally Occurring DNA Segments
McGuireWoods
June 17, 2013
2 pages
What Does the Future Hold in View of the Supreme Court Decision on Isolated Genes and cDNA?
White & Case
June 17, 2013
2 pages
Association for Molecular Pathology v. Myriad Genetics, Inc.
Bingham
June 17, 2013
3 pages
Patent Eligibility Considerations Following the Supreme Court’s Myriad Ruling
Skadden
June 17, 2013
4 pages
U.S. Supreme Court Myriad Decision Strikes a Compromise on the Patentability of Human Genes
Kirkland & Ellis
June 17, 2013
3 pages
